Status:
NOT_YET_RECRUITING
Exercise Rehabilitation for Cardiorenal Syndrome in HFrEF Patients
Lead Sponsor:
Haiyan Pan
Conditions:
Cardiorenal Syndrome
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This study aims to investigate the efficacy and safety of exercise rehabilitation in patients with cardiorenal syndrome (CRS). Building on previous research demonstrating that exercise rehabilitation...
Detailed Description
This study is designed to evaluate the efficacy and safety of home-based exercise rehabilitation as an adjuvant intervention for patients with Cardiorenal Syndrome (CRS) complicated by Chronic Heart F...
Eligibility Criteria
Inclusion
- Patients with chronically stable HFrEF complicated by kidney dysfunction (eGFR \< 90 mL/min/1.73m²)
- NYHA class II-III
- Low risk in exercise risk assessment
- Aged 18-75 years
Exclusion
- Uncontrolled hypertension
- Severe arrhythmias (including frequent ventricular premature contractions, ventricular tachycardia, rapid atrial fibrillation, sick sinus syndrome, and second-degree or higher atrioventricular block)
- Obstructive hypertrophic cardiomyopathy
- Moderate to severe stenotic valvular heart disease
- Deep vein thrombosis or pulmonary embolism
- History of syncope
- Severe anemia
- Abnormal thyroid function
- Severe pulmonary diseases
- Mental illnesses
- Osteoarticular or muscular diseases that impede rehabilitation training
Key Trial Info
Start Date :
September 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT07167368
Start Date
September 15 2025
End Date
December 31 2027
Last Update
September 11 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.